Temporal changes in treatment patterns by age group and functional status before and after PD-1/L1 inhibitor approvals in advanced urothelial carcinoma

INTRODUCTION: Metastatic urothelial carcinoma (mUC) has poor prognosis. A high unmet need exists for novel treatment for those who are unfit for platinum-based chemotherapy. METHODS: We aimed to describe real-world temporal changes in patient characteristics and 1L treatment selection for mUC patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Doshi, Gurjyot K., Li, Haojie, Burcu, Mehmet, Annavarapu, Srinivas, Wells, Karen, Imai, Kentaro, Moreno, Blanca Homet, Singhal, Puneet, Mamtani, Ronac
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10577172/
https://www.ncbi.nlm.nih.gov/pubmed/37849801
http://dx.doi.org/10.3389/fonc.2023.1210208

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10577172/
https://www.ncbi.nlm.nih.gov/pubmed/37849801
http://dx.doi.org/10.3389/fonc.2023.1210208

Ejemplares similares